5.74
-0.04
(-0.69%)
May 21 - Close
NASDAQ
real-time data -
Disclaimer
Currency in USD
| Range | 5.51 - 5.88 |
| 52 week | 1.20 - 5.88 |
| Open | 5.87 |
| Vol / Avg. | 0.00/502,716.00 |
| Mkt cap | 144.21M |
| P/E | - |
| Div/yield | - |
| EPS | -1.80 |
| Shares | 25.12M |
| Beta | 2.43 |
| Inst. own | 38% |
Events
Jul 22, 2013
Q3 2013 Hutchinson Technology Earnings Release
Apr 30, 2013
Q2 2013 Hutchinson Technology Earnings Conference Call -
Apr 30, 2013
Q2 2013 Hutchinson Technology Earnings Release
|
More events from DailyFinance »
|
Key stats and ratios
| Q4 (Dec '12) | 2012 | |
| Net profit margin | -10.24% | -19.57% |
| Operating margin | -4.87% | -13.77% |
| EBITD margin | - | 0.04% |
| Return on average assets | -7.71% | -13.19% |
| Return on average equity | -15.89% | -26.00% |
| Employees | 2,060 | - |
| Carbon Disclosure Rating | - | - |
Address
40 West Highland Park Drive NE
HUTCHINSON, MN 55350-9784
United States - Map
+1-320-5873797 (Phone)
+1-320-5871810 (Fax)
HUTCHINSON, MN 55350-9784
United States - Map
+1-320-5873797 (Phone)
+1-320-5871810 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
Hutchinson Technology Incorporated (HTI) is a global technology manufacturer. The Company is a supplier of suspension assemblies for hard disk drives. The Company operates in two segments: the Disk Drive Components Division and the BioMeasurement Division. Its Disk Drive Components Division is a global supplier of suspension assemblies for hard disk drives. Suspension assemblies are electro-mechanical components that hold a disk drive�s read/write head at microscopic distances above the drive�s disks. Its BioMeasurement Division is focused on bringing technologies and products to the market that provide information clinicians. InSpectra StO2 devices provide clinicians the ability to detect changes in a patient�s perfusion status, and help in the early detection of hypoperfusion to enable assessment of oxygen delivery to vital organs and tissue in critical care settings.
Officers and directors
| Wayne M. Fortun | Chairman of the Board | |
| Richard J. Penn | President, Chief Executive Officer, Director | |
| David P. Radloff | Chief Financial Officer, Vice President | |
| Jose Carlos Rodriguez Moreno | Chief Operating Officer | |
| Dale M. Ruzicka | Vice President - Operations | |
| R. Scott Schaefer | Vice President, Chief Technical Officer | |
| Connie L. Pautz | Vice President - Human Resources and Corporate Communications | |
| Russell Huffer | Lead Independent Director | |
| Martha Goldberg Aronson | Independent Director | |
| William T. Monahan | Independent Director |